Page last updated: 2024-11-02

pamidronate and Uveitis, Posterior

pamidronate has been researched along with Uveitis, Posterior in 1 studies

Uveitis, Posterior: Inflammation of the choroid as well as the retina and vitreous body. Some form of visual disturbance is usually present. The most important characteristics of posterior uveitis are vitreous opacities, choroiditis, and chorioretinitis.

Research Excerpts

ExcerptRelevanceReference
" Pamidronate, an inhibitor of bone resorption used primarily in the management of tumor-induced hypercalcemia and Paget's disease, is reported to cause conjunctivitis, anterior uveitis, and infrequently episcleritis and scleritis."3.72Posterior uveitis: an under-recognized adverse effect of pamidronate: 2 case reports. ( Claes, C; Haverbeke, G; Pertile, G; Zeyen, T, 2003)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Haverbeke, G1
Pertile, G1
Claes, C1
Zeyen, T1

Other Studies

1 other study available for pamidronate and Uveitis, Posterior

ArticleYear
Posterior uveitis: an under-recognized adverse effect of pamidronate: 2 case reports.
    Bulletin de la Societe belge d'ophtalmologie, 2003, Issue:290

    Topics: Bone Neoplasms; Bone Resorption; Carcinoma; Conjunctivitis; Diphosphonates; Fatal Outcome; Humans; M

2003